A carregar...

Advances in immunotherapy for the treatment of glioblastoma

Glioblastoma (GBM) is an aggressive brain tumour, associated with extremely poor prognosis and although there have been therapeutic advances, treatment options remain limited. This review focuses on the use of immunotherapy, harnessing the power of the host’s immune system to reject cancer cells. Ke...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Neurooncol
Main Authors: Tivnan, Amanda, Heilinger, Tatjana, Lavelle, Ed C., Prehn, Jochen H. M.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5258809/
https://ncbi.nlm.nih.gov/pubmed/27743144
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-016-2299-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!